Effect of chlorpromazine and clozapine on plasma concentrations of haloperidol in a patient with schizophrenia

Journal of Clinical Pharmacology

Volumn 40, Issue 11, 2000, Pages 1296-1297

  Allen, S A ^a  

^a SGAPS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE MESILATE; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL DECANOATE; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG MONITORING; ENZYME INHIBITION; HUMAN; MALE; MENTAL DISEASE; PSYCHOSIS; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; CLOZAPINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HALOPERIDOL; HUMANS; MALE; SCHIZOPHRENIA;

EID: 0033753010     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Inhibitory studies of mexiletine and dextromethorphan oxidation in human liver microsomes
2. In vitro forecasting of drugs that may interfere with codeine bioactivation
3. Increases in plasma concentration of m-chlorophenylpiperazine, but not trazodone, with low-dose haloperidol
4. Pharmacokinetic interactions involving clozapine
5. Dose-dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer
6. Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia
7. Antipsychotic polypharmacy, part I: Therapeutic option or dirty little secret?
8. Violence in schizophrenia: The roles of psychosis and psychopathy